Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × tipifarnib × Clear all

NCT03496766 2025-03-05

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Phase 2 Terminated

9 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT00055757 2013-06-04

Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00005989 2011-08-04

R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms